Oxurion Nv Is A Biopharmaceutical Company Based In Leuvenbelgiumfounded In 1991The Companypreviously Known As Thrombogenics Nvrebranded To Oxurion Nv In September 2018 And Is Listed On Euronext Brussels Under The Ticker Symbol Oxur Oxurion S Mission Is To Prevent Blindness By Developing Innovative Therapies For Retinal Diseasesparticularly Age Related Macular Degenerationamdand Geographic Atrophythe Company Utilizes A Crispr Based Target Discovery Platform To Identify Cytoprotective Targetsfocusing On Addressing Unmet Medical Needs In Ophthalmologywith A Dedicated Team Of Around 20 Employeesoxurion Is Committed To Creating Next Generation Treatments Aimed At Improving And Preserving Vision For Patients With Retinal Disorders
No conferences found for this company.
| Company Name | Oxurion Thrombogenics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
